Nobiletin regulates intracellular Ca2+ levels via IP3R and ameliorates neuroinflammation in Aβ42-induced astrocytes

Redox Biol. 2024 Jul:73:103197. doi: 10.1016/j.redox.2024.103197. Epub 2024 May 16.

Abstract

Astrocytes are the major glial cells in the human brain and provide crucial metabolic and trophic support to neurons. The amyloid-β peptide (Aβ) alter the morphological and functional properties of astrocytes and induce inflammation and calcium dysregulation, contributing to Alzheimer's disease (AD) pathology. Recent studies highlight the role of Toll-like receptor (TLR) 4/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling in inflammation. Reactive oxygen species (ROS) generated due to Aβ, induce apoptosis in the brain cells worsening AD progression. Astrocytic cell surface receptors, such as purinergic receptors (P2Y1 and P2Y2), metabotropic glutamate receptor (mGLUR)5, α7 nicotinic acetylcholine receptor (α7nAChR), and N-methyl-d-aspartate receptors (NMDARs), have been suggested to interact with inositol trisphosphate receptor (IP3R) on the endoplasmic reticulum (ER) to induce Ca2+ movement from ER to cytoplasm, causing Ca2+ dysregulation. We found that the citrus flavonoid nobiletin (NOB) protected primary astrocytes from Aβ42-induced cytotoxicity and inhibited TLR4/NF-κB signaling in Aβ42-induced primary rat astrocytes. NOB was found to regulate Aβ42-induced ROS levels through Keap1-Nrf2 pathway. The receptors P2Y1, P2Y2, mGLUR5, α7nAChR, and NMDARs induced intracellular Ca2+ levels by activating IP3R and NOB regulated them, thereby regulating intracellular Ca2+ levels. Molecular docking analysis revealed a possible interaction between NOB and IP3R in IP3R regulation. Furthermore, RNA sequencing revealed various NOB-mediated biological signaling pathways, such as the AD-presenilin, AD-amyloid secretase, and Wnt signaling pathway, suggesting possible neuroprotective roles of NOB. To conclude, NOB is a promising therapeutic agent for AD and works by modulating AD pathology at various levels in Aβ42-induced primary rat astrocytes.

Keywords: Alzheimer's disease; Calcium dysregulation; Citrus flavonoid; Neuroinflammation; Nobiletin.

MeSH terms

  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Amyloid beta-Peptides* / metabolism
  • Animals
  • Astrocytes* / drug effects
  • Astrocytes* / metabolism
  • Calcium* / metabolism
  • Flavones* / pharmacology
  • Humans
  • Inositol 1,4,5-Trisphosphate Receptors* / metabolism
  • Neuroinflammatory Diseases / drug therapy
  • Neuroinflammatory Diseases / metabolism
  • Peptide Fragments / metabolism
  • Peptide Fragments / pharmacology
  • Rats
  • Reactive Oxygen Species / metabolism
  • Signal Transduction / drug effects
  • Toll-Like Receptor 4 / metabolism

Substances

  • Amyloid beta-Peptides
  • Inositol 1,4,5-Trisphosphate Receptors
  • nobiletin
  • Calcium
  • Flavones
  • Reactive Oxygen Species
  • amyloid beta-protein (1-42)
  • Peptide Fragments
  • Toll-Like Receptor 4
  • Itpr1 protein, rat